MTCM
AGN

Mint Tower Capital Management’s Allergan plc AGN Stock Holding History

Mint Tower Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,000
Closed -$353K – 378
2020
Q1 		$353K Sell
2,000
-9,000
-82% -$1.69M 0.07% 152
2019
Q4 		$2.1M Buy
11,000
+4,000
+57% +$722K 0.28% 109
2019
Q3 		$1.18M Buy
7,000
+2,000
+40% +$326K 0.17% 105
2019
Q2 		$833K Buy
+5,000
New +$692K 0.09% 165

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Mint Tower Capital Management's AGN Position: Q2 2020 in Review

Mint Tower Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,000 shares — an estimated $353K sold.

Mint Tower Capital Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $2.1M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Mint Tower Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Mint Tower Capital Management sold 2,000 Allergan plc shares in Q2 2020, an estimated $353K.
  • Mint Tower Capital Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Mint Tower Capital Management's Allergan plc position peaked at $2.1M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Mint Tower Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.